pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

2,991 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT1783Endpoints1390Fierce Biotech710BioSpace698BioPharma Dive525raps234onclive165fda recalls113
therapy area
allOncology12325Rare Disease3219Immunology2863Cardiology2745Hematology2177Pulmonology2143Vaccines
  • Panel reviews clinical trial landscape and new strategies for recurrent endometrial cancer after checkpoint inhibitor failure
    A recent expert panel has examined the current state of clinical trials targeting recurrent endometrial cancer. The discussion highlighted that many patients now face disease progression after rec…
    onclive · 6mo agoNeutral↗ source
  • Hospitals restricting doctors' social media posts may worsen health misinformation, says physician
    Adam Goodcoff, chief medical officer at HealthCentral, began creating health content online while in medical school, using short videos to explain procedures and counter myths, such as the depth of…
    STAT · 6mo agoNegative↗ source
← prev
page 108 of 120
next →
fda medwatch111
globenewswire health73
fda press59
1796
Psychiatry & CNS1204
Ophthalmology1060
Pain777
Endocrinology & Metabolism776
Nephrology760
Experts outline safety strategies for radiopharmaceutical treatment of advanced prostate cancer
Dr. Johann De Bono and Dr. Pedro Barata presented a discussion focused on practical methods for monitoring and managing toxicities that arise from radiopharmaceutical therapies used in metastatic c…
onclive · 6mo agoNeutral↗ source
  • Experts issue consensus guidance on lymphoma testing and treatment strategies
    Experts presented consensus recommendations for lymphoma management at the 2025 Bridging the Gaps meeting. For mantle cell lymphoma, the panel advised comprehensive testing for TP53 mutations and…
    onclive · 6mo agoNeutral↗ source
  • Experts discuss combining radiopharmaceuticals with systemic therapies for advanced prostate cancer
    Dr. Pedro Barata and Dr. Johann de Bono presented a discussion on emerging combination strategies that pair radiopharmaceuticals with other systemic treatments for metastatic castration-resistant p…
    onclive · 6mo agoNeutral↗ source
  • CMS pauses enrollment of new hospice and home health providers for six months
    CMS announced a six-month moratorium on enrolling new hospice and home health agencies. The pause is part of the Trump administration's broader effort to curb fraud, waste, and abuse in Medicare s…
    STAT · 6mo agoRegulatoryNeutral↗ source
  • STAT+ reveals hidden issues in FDA's AI medical device approval pathway
    Brittany Trang, a health‑tech reporter, published a STAT+ newsletter piece that examines how the FDA handles AI‑driven medical devices. The article highlights the lack of transparency in the agency…
    STAT · 6mo agoNegative↗ source
  • Expert Answers Common Questions on Esophageal Cancer Diagnosis and Treatment
    Dr. Peter Enzinger, a recognized specialist in esophageal oncology, sits down for a clinician‑focused FAQ interview that tackles the most frequently asked questions about the disease. The conversa…
    onclive · 6mo agoNeutral↗ source
  • Oncologist Charles Blanke reflects on cancer research journey and push for medical aid in dying
    The latest episode of the "How This Is Building Me" podcast features D. Ross Camidge, MD, PhD, speaking with Charles D. Blanke, MD, a professor at Oregon Health & Science University. The conversati…
    onclive · 6mo agoPositive↗ source
  • FDA commissioner resigns as Marty Makary steps down, Bill Cassidy faces tough primary
    The newsletter highlights that extreme heat is worsening faster for Black Americans, underscoring a growing health disparity. FDA Commissioner Marty Makary resigned yesterday, and Kyle Diamantas,…
    STAT · 6mo agoRegulatoryNeutral↗ source
  • RFK Jr.’s antidepressant deprescribing campaign praised for awareness but flagged as unsafe without proper support
    A clinical professor of psychiatry at Columbia University writes that Robert F. Kennedy Jr.'s push to deprescribe antidepressants raises public attention but lacks the clinical infrastructure neede…
    STAT · 6mo agoNegative↗ source
  • Sen. Bill Cassidy’s impeachment vote and RFK Jr. confirmation jeopardize his political future
    Sen. Bill Cassidy, a former physician turned lawmaker, has taken political actions that threaten his standing in Louisiana. He voted to impeach former President Donald Trump and supported the confi…
    STAT · 6mo agoNegative↗ source
  • CDC says hantavirus risk to public remains low despite cruise ship outbreak
    Two CDC doctors told reporters the risk of hantavirus to the general public is low and that the agency is engaged at every step of the response. They outlined a coordinated effort that includes st…
    STAT · 6mo agoNeutral↗ source
  • Podcast explores the limits of "blue zones" concept in aging research
    On a recent First Opinion podcast, medical journalist Shelley Wood and cardiologist Eric Topol discussed the "blue zones" concept and its relevance to aging research. They traced the idea back to…
    STAT · 6mo agoNeutral↗ source
  • FDA approves vepdegestrant for ESR1-mutated ER-positive advanced breast cancer
    On May 1, 2026 the FDA gave its first approval to vepdegestrant, an oral selective estrogen receptor degrader, for adult patients with estrogen receptor-positive, HER2-negative breast cancer that c…
    onclive · 6mo agoApprovalPositive↗ source
  • Bristol Myers Squibb signs up to $15.2 billion partnership with China's Hengrui Pharma
    Bristol Myers Squibb announced a licensing partnership with China's Hengrui Pharma covering more than a dozen early-stage drug programs. The agreement includes a $600 million upfront payment to He…
    STAT · 6mo agoDealPositive↗ source
  • Alcohol epidemic claims nearly 500 U.S. lives daily, exposing systemic public-health failures
    The investigative series "The Deadliest Drug" surveyed more than 100 health researchers, clinicians, patients, industry insiders and lawmakers, and examined scientific literature, treatment protoco…
    STAT · 6mo agoNegative↗ source
  • Supreme Court grants three-day extension on ruling over abortion drug mifepristone
    The U.S. Supreme Court announced it will take an additional three days before issuing a decision in the case concerning the abortion medication mifepristone. The case, Louisiana v. FDA, reached th…
    STAT · 6mo agoRegulatoryNeutral↗ source
  • Pharma leaders risk industry collapse by over-relying on Chinese drug sourcing, says analyst
    Olivia Kosloff, a senior fellow at the American Economic Liberties Project and co-chair of a Council on Foreign Relations working group, argues that U.S. pharma and biotech executives are jeopardiz…
    STAT · 6mo agoNegative↗ source
  • Former FDA Commissioner Marty Makary resigns under pressure, critics call his tenure the weakest in 25 years
    Marty Makary stepped down as FDA commissioner on Tuesday after mounting pressure, ending a tenure that many observers described as the weakest in the agency’s recent history. Critics said he lacke…
    STAT · 6mo agoRegulatoryNegative↗ source
  • EU drafts Critical Medicines Act to increase local production and curb drug shortages
    The European Union has reached a provisional agreement known as the Critical Medicines Act, aimed at strengthening the supply of essential medicines across member states. The plan focuses on incre…
    STAT · 6mo agoRegulatoryPositive↗ source
  • FDA Commissioner Marty Makary resigns amid internal turmoil, top food regulator Kyle Diamantas to serve as acting chief
    Food and Drug Administration Commissioner Marty Makary is leaving his post after serving a little over a year, according to an administration source. His tenure was marked by staff departures and i…
    STAT · 6mo agoRegulatoryNegative↗ source
  • Hims sales dip as telehealth rivals intensify; Bristol partners with Chinese firm, other biotech updates
    Hims reported lower sales this quarter, attributing the shortfall to growing competition from other telehealth providers. Bristol announced a new partnership with Chinese drugmaker Hengrui Pharma…
    STAT · 6mo agoNeutral↗ source
  • FDA grants breakthrough therapy designation to Emi-Le for advanced adenoid cystic carcinoma
    The U.S. Food and Drug Administration has granted breakthrough therapy designation to Emi-Le for patients with locally advanced, recurrent or metastatic adenoid cystic carcinoma (ACC). Phase 1 tri…
    onclive · 6mo agoCRLPositive↗ source
  • Phase 1 trial shows safety and early PSA responses for novel PSMA radioligand in mCRPC
    A Phase 1 study evaluated the long‑circulating PSMA therapeutic radioligand [177Lu]Lu‑D‑Dan‑Phe‑PSMA in patients with metastatic castration‑resistant prostate cancer. The trial enrolled several dos…
    onclive · 6mo agoPositive readoutPositive↗ source